Skip to content

Long-term Follow-up of Subfoveal Neovascular AMD

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01608113
Enrollment
70
Registered
2012-05-30
Start date
2011-09-30
Completion date
Unknown
Last updated
2012-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exudative Age-related Macular Degeneration

Keywords

neovascular AMD, Optical coherence tomography, reading acuity, contrast sensitivity

Brief summary

Treatment naive patients with subfoveal nAMD initially treated monthly with intravitreal anti-VEGF and subsequently PRN, will be included in this study. Patients will be investigated for the first 2 years monthly and subsequently according to disease activity but at least every two months. Patients will be examined with 4m BCVA ETDRS distance visual acuity, reading acuity measured by Radner-Reading-Charts, contrast sensitivity by Pelli-Robson score, microperimetry and HD-OCT.

Interventions

None listed

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* treatment naive subfoveal AMD, written informed consent, able to read

Exclusion criteria

* choroidal neovascularisation due to other ocular diseases, mature cataract

Design outcomes

Primary

MeasureTime frame
Long-term visual function performancefour years

Secondary

MeasureTime frame
change of morphological alterations assessed by SD-OCTfour years

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026